|
|
|
|
Return to Savvy Consumer Information Center - Home Page |
Current
Research
The leading role in osteoarthritis
research is played by the National Institute of Arthritis and
Musculoskeletal and Skin Diseases (NIAMS), within the National
Institutes of Health (NIH). The NIAMS funds many researchers across
the United States to study osteoarthritis. It has established a
Specialized Center of Research devoted to osteoarthritis. Also, a
large number of researchers study arthritis at the NIAMS Multipurpose
Arthritis and Musculoskeletal Disease Centers. These centers conduct
basic, laboratory, and clinical research aimed at understanding the
causes, treatment options, and prevention of arthritis and
musculoskeletal diseases. Center researchers also study professional,
patient, and public education; epidemiology; and health services. |
Genetic
Studies: Researchers suspect that inheritance plays a role
in 25 to 30 percent of osteoarthritis cases. Scientists have
identified a mutation (a gene defect) affecting collagen, an important
part of cartilage in patients with an inherited kind of osteoarthritis
that starts at an early age. The mutation weakens collagen protein,
which may break or tear more easily under stress. Scientists are
looking for other mutations in osteoarthritis. In the future, a test
to determine who carries the genetic defect (or defects) could help
people reduce their risk for osteoarthritis with lifestyle
adjustments. Exercise plays a key part in comprehensive treatment. Researchers are studying exercise in greater detail, finding out just how to use it in treating or preventing osteoarthritis. For example, several scientists have looked at knee osteoarthritis and exercise. They have found that
Using NSAIDs: Many patients have pain that persists despite the use of simple pain relievers like acetaminophen. Some of these patients use NSAIDs instead. Health care providers are concerned about long-term NSAID use because dangerous side effects can result. Scientists are working to design and test new, safer NSAIDs. One example currently available is a class of drugs called COX-2 inhibitors. These medicines relieve symptoms and are less likely to produce serious side effects such as stomach ulcers and bleeding, which are associated with long-term NSAID use. |
Drugs To
Prevent Joint Damage: No treatment actually prevents
osteoarthritis or reverses or blocks the disease process once it
begins. Present treatments just relieve the symptoms. Researchers are
looking for drugs that would prevent, slow down, or reverse joint
damage. One experimental antibiotic drug, doxycycline, may stop
certain enzymes from damaging cartilage. The drug has responded well
in clinical studies, but more studies are needed. Researchers are also
studying growth factors or other natural chemical messengers. These
potential medicines may be able to stimulate cartilage growth or
repair.
|
Hyaluronic Acid:
Injecting this substance into
the knee joint provides long-term pain relief for some people with
osteoarthritis. Hyaluronic acid is a natural component of cartilage
and joint fluid. It lubricates and absorbs shock in the joint. The
Food and Drug Administration (FDA) recently approved this therapy for
patients with osteoarthritis of the knee if they do not get relief
from exercise, physical therapy, or simple analgesics. Researchers are
testing whether hyaluronic acid can slow down the progression of
osteoarthritis.
|
Return to Savvy Consumer Information Center - Home Page |
|
|
|
|
Get the Savvy Consumer Newsletter! (FREE) |